ProShare Advisors’s Inhibrx, Inc. Common Stock INBX Stock Holding History

ProShare Advisors’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-16,741	Closed	-$585K	–	2051
2024 Q1	$585K	Buy	16,741 +8,033	+92%	+$293K	﹤0.01%	994
2023 Q4	$331K	Buy	+8,708	New	+$187K	﹤0.01%	1302
2022 Q2	–	Sell	-9,273	Closed	-$206K	–	2285
2022 Q1	$206K	Sell	9,273 -2,168	-19%	-$55.3K	﹤0.01%	1872
2021 Q4	$500K	Buy	+11,441	New	+$458K	﹤0.01%	1442

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

ProShare Advisors's INBX Position: Q2 2024 in Review

ProShare Advisors sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 16,741 shares — an estimated $585K sold.

ProShare Advisors first reported a position in INBX in Q4 2021 and held it in 4 quarters. The position peaked at $585K in Q1 2024. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

ProShare Advisors reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
ProShare Advisors sold 16,741 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $585K.
ProShare Advisors first reported a position in Inhibrx, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
ProShare Advisors's Inhibrx, Inc. Common Stock position peaked at $585K in Q1 2024.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on ProShare Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.